Nachrichten zur Hims & Hers Health Aktie

Hims & Hers Valuations Back To Earth - Robust Monetization Trends Deserve Reiterated Buy

…

Hims & Hers data breach exposes customer support data

The breach was a result of a social engineering attack, where hackers tricked employees into granting system access.…

Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…

Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100%…

Hims & Hers flags suspicious activity linked to third?party customer service vendor

Hims & Hers Health Inc NYSE:HIMS:…

Hims & Hers Data Breach Lawsuit Investigation

If you were affected by the Hims & Hers data breach, you may be entitled to compensation.…

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after reports revealed that the US may impose up…

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know…

Broad selling pressure keeps Hims & Hers stock restrained after telehealth expansion news

Hims & Hers trades at $19.19 today, down 3.28%. See the latest price action and outlook amid heightened volatility.…

Hims & Hers Data Breach Exposes Customer Service Records

Hims & Hers data breach exposed customer names and contact info. If you were affected, learn what happened and your…

Why Hims & Hers Health Stock Is Sinking Now

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

-3.88% for Hims & Hers Health stock as oscillators give mixed signals near session low

Hims & Hers Health trades at $19.96 today, down 3.88%. Latest signals suggest high volatility and short-term bearish pressure.…

Hims & Hers Stock Is Down 63% Over the Past 6 Months. Here’s Why the Valuation Still Looks Compelling

Here’s why Hims & Hers (HIMS) stock could still deliver strong returns after a steep 2026 selloff.…

Novo partnership fuels long-term optimism for Hims & Hers Health, Inc. (HIMS)

Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Stocks to Buy for Short Term. On March 27,…

Novo Partnership Fuels Long-Term Optimism for Hims & Hers Health, Inc. (HIMS)

Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Stocks to Buy for Short Term. On March 27,…

Novo Partnership Fuels Long-Term Optimism for Hims & Hers Health, Inc. (HIMS)

Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Best Stocks to Buy for Short Term. On March 27,…

Did Hims & Hers Novo Nordisk GLP-1 Partnership Just Shift Hims & Hers Healths (HIMS) Investment Narrative?

In March 2026, Hims & Hers Health announced a collaboration with Novo Nordisk to offer eligible customers a broad range…

Hims & Hers Expands Personalized Digital Healthcare Platform

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.…

Why Hims & Hers Health Stock Is Surging Now

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Hims & Hers Expands Personalized Digital Healthcare Platform

Hims & Hers Health, Inc. HIMS is building a consumer-first digital healthcare platform that integrates diagnosis, treatment and fulfillment into…

Hims & Hers Expands Personalized Digital Healthcare Platform

HIMS builds a digital-first healthcare platform, integrating telehealth, AI and personalized treatments while expanding globally and into new specialties.…

Hims & Hers Expands Personalized Digital Healthcare Platform

HIMS builds a digital-first healthcare platform, integrating telehealth, AI and personalized treatments while expanding globally and into new specialties.…

Novo to sell Wegovy subscriptions on Hims, LifeMD, and others

Novo Nordisk (NVO) stock is in focus as the company launches a Wegovy subscription program via telehealth firms including Hims…

Hims & Hers Expands Personalized Digital Healthcare Platform

HIMS builds a digital-first healthcare platform, integrating telehealth, AI and personalized treatments while expanding globally and into new specialties.…

Hims Novo Nordisk GLP-1 Launch Ties Growth Story To Valuation Gap

Hims & Hers Health (NYSE:HIMS) has launched access to Novo Nordisk FDA-approved GLP-1 medications for eligible patients.The offering includes a…

Hims & Hers Health, Inc. (HIMS) Registers a Bigger Fall Than the Market: Important Facts to Note

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $18.78, denoting a -3.1%…

Hims & Hers Health, Inc. (HIMS) Registers a Bigger Fall Than the Market: Important Facts to Note

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $18.78, denoting a -3.1%…

Why (HIMS) Price Action Is Critical for Tactical Trading

Price-action only: Hims & Hers Health Inc. Class A (HIMS) movements set the tone for institutional models. Why (HIMS) Price…

Hims & Hers Health Aktie: Weight-Watchers-Offensive erhöht den Druck

New York (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von TD Cowen:Die Analysten von TD Cowen stufen die Aktie von Hims…

Assessing Hims & Hers Health (HIMS) Valuation After A Sharp Pullback And Long Term Shareholder Gains

Recent performance snapshotHims & Hers Health (HIMS) has drawn investor attention after a mixed run, with the share price near…

Hims & Hers Health stock price forecast: persistent bearish setup as HIMS extends decline toward $18

Hims & Hers Health trades at $19.38 today, down 7.09%. Check out the latest price action and daily performance update.…

SG Americas Securities LLC Boosts Stock Position in Hims & Hers Health, Inc. $HIMS

SG Americas Securities LLC raised its holdings in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 25.6%…

Hims & Hers Stock Decline Amid Legal Battles and Strategic Repositioning

Hims & Hers Health Inc. stocks have been trading down by -7.02% amid cautious investor sentiment over leadership changes. Key…

TD Cowen Has Lowered Expectations for Hims & Hers Health (NYSE:HIMS) Stock Price

TD Cowen lowered their target price on shares of Hims & Hers Health from $25.00 to $23.00 and set a…

Hims & Hers Health Launches Offering Featuring Novo Nordisk Products

Hims & Hers Health announced that, as of yesterday, it is providing direct access to Wegovy tablets, Wegovy injections,…

Why Hims & Hers Health Stock Is Sinking Now

Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…

Hims & Hers: The Reset Before The Next Inflection

Hims & Hers Health shares rallied to ~$27 after the early-March Novo deal before resetting to ~$20. Click here to…

Hims & Hers price target lowered to $23 from $25 at TD Cowen

TD Cowen lowered the firm’s price target on Hims Hers to $23 from $25 and keeps a Hold rating…

From Breaking Stigma to Building the Future of Health

Hims & Hers began by dismantling the barriers to essential care, turning stigmatized conversations into accessible, evidence-based solutions for hair…

Hims & Hers Health Aktie: Neue Wegovy-Mitgliedschaft teurer als gedacht - BofA warnt vor Risiken im GLP-1-Geschäft

Charlotte (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von BofA Securities:Allen Lutz, Analyst von BofA Securities, stuft die Aktie von Hims…

Buy Rating on Hims & Hers: Undervalued Growth Leveraging Novo Nordisk GLP-1 Partnership and Scale Advantages

Hims & Hers Health, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Maria Ripps from…

Canaccord reiterates Hims and Hers stock rating on Novo launch

Canaccord reiterates Hims and Hers stock rating on Novo launch…

Hims & Hers shifts business model after Novo deal

Hims & Hers is moving toward branded GLP-1s and deeper pharma partnerships, shifting to a potential platform for drug distribution.…

Hims & Hers Health (HIMS) price target decreased by 14.58% to 25.63

The average one-year price target for Hims & Hers Health (NYSE:HIMS) has been revised to $25.63 / share. This is…

HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise

Low-cost healthcare services provider Hims Hers ($HIMS) on Thursday disclosed the availability of approved versions of Novo Nordisk’s ($NVO)…

Hims and Hers stock price target maintained at $23 by BofA Securities

Hims and Hers stock price target maintained at $23 by BofA Securities…

Hims and Hers stock price target maintained at $23 by BofA Securities

Hims and Hers stock price target maintained at $23 by BofA Securities…

Hims and Hers stock price target maintained at $23 by BofA Securities

Hims and Hers stock price target maintained at $23 by BofA Securities…